Service de Chirurgie Orthopédique et Traumatologie, CHU Amiens-Picardie, 80480, Salouël, France.
Service de Chirurgie Orthopédique et Traumatologie, CHU Amiens-Picardie, 80480, Salouël, France.
Orthop Traumatol Surg Res. 2022 Sep;108(5):103320. doi: 10.1016/j.otsr.2022.103320. Epub 2022 May 13.
Revision of total knee arthroplasty (rTKA) for suspicion of metal hypersensitivity (MHS) may require hypoallergenic implants. Results for coated implants have not been reported. The aim of the present study was to assess short-term results and survival of rTKA for MHS using a multilayer implant coating.
Multilayer implant coating improves functional results in rTKA, with survival comparable to primary coated implants.
A single-center retrospective observational study included 28 patients (30 knees) undergoing rTKA for MHS using a coated implant between May 2011 and November 2016. Exclusion criteria comprised implant malpositioning and history of infection in the affected knee. Clinical and radiological results were assessed on the International Knee Society (IKS) and SF-36 functional scores and Ewald radiological score. Survival was calculated on Kaplan-Meier estimation.
Mean follow-up was 3.8 years. Mean IKS score increased by 40.2 points (40%) [range, 28.1-52.3] (p<0.05). Mean range of motion increased by 17° [range, 9.5-24.5°] (p<0.05). Mean physical and mental SF-36 components were respectively 44.7 and 46.1. Survivorship was 93%.
There was significant functional improvement after rTKA for MHS. There were no short-term complications related to the zirconium nitrate coating. However, studies with longer follow-up will be needed for confirmation.
IV; retrospective study.
怀疑金属过敏(MHS)的全膝关节翻修术(rTKA)可能需要低致敏性植入物。涂层植入物的结果尚未报道。本研究的目的是评估使用多层植入物涂层治疗 MHS 的 rTKA 的短期结果和存活率。
多层植入物涂层可改善 rTKA 的功能结果,其存活率可与原发性涂层植入物相媲美。
单中心回顾性观察性研究纳入 2011 年 5 月至 2016 年 11 月期间因 MHS 接受涂层植入物 rTKA 的 28 例患者(30 膝)。排除标准包括植入物位置不当和受影响膝关节感染史。临床和影像学结果采用国际膝关节学会(IKS)和 SF-36 功能评分和 Ewald 影像学评分进行评估。通过 Kaplan-Meier 估计计算生存率。
平均随访 3.8 年。IKS 评分平均增加 40.2 分(40%)[范围,28.1-52.3](p<0.05)。平均活动范围增加 17°[范围,9.5-24.5°](p<0.05)。平均身体和精神 SF-36 成分分别为 44.7 和 46.1。生存率为 93%。
MHS 的 rTKA 后功能显著改善。与硝酸氧锆涂层无关的短期并发症。然而,需要进行更长时间的随访研究来确认。
IV;回顾性研究。